ArticleJournal of neurochemistry2026
A Novel Mouse Model of Sympathoadrenal Catecholamine Deficiency by Ablation of the Tyrosine Hydroxylase Gene With Slc6a4-Cre.
Article in Journal of neurochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Catecholamines (CAs) play important roles not only in the central nervous system but also in the periphery. Tyrosine hydroxylase (TH) is the rate-limiting enzyme for CA synthesis and selective Th ablation in tissues of interest is useful to investigate the physiological function of locally produced CAs. Slc6a4 encodes serotonin transporter (SERT), a membrane transporter for serotonin reuptake, which is reported to be expressed in several peripheral tissues as well as serotonin-producing cells. Here, we report a novel Th conditional knockout mouse line generated by Slc6a4-Cre. The conditional knockout mice (cKO mice) exhibited predominant depletion of adrenaline in the adrenal glands, while noradrenaline contents were preserved at approximately 70% of control levels. TH expression was largely lost, although sparsely retained, in the adrenal medulla of cKO mice contrary to unaltered expression of TH in the brain. In addition to the adrenal gland, TH expression was lost in approximately 80% of sympathetic neurons in the superior mesenteric ganglion of cKO mice. Plasma noradrenaline levels were significantly reduced, although plasma dihydroxyphenylalanine (DOPA) levels were comparable to those of controls. Bradycardia and changes in heart rate variability in cKO mice suggested impaired sympathoadrenal catecholaminergic regulation of the heart. The present data highlight the value of these cKO mice as a useful tool for elucidating the properties of the sympathoadrenal catecholaminergic system independently of the brain noradrenergic system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.